HILLHURST BIO RECEIVES GRANT SUBAWARD FROM THE FARMER FAMILY FOUNDATION AND GRANT AWARD FROM THE MICHAEL J. FOX FOUNDATION TO ADVANCE CLINICAL DEVELOPMENT IN PARKINSON'S DISEASE

SAN DIEGO, May 8, 2025 /PRNewswire/ -- Hillhurst Biopharmaceuticals, Inc. ("Hillhurst Bio"), a clinical-stage biopharmaceutical company pioneering novel liquid drug products, today announced $6.3 million in grant awards to fund its Phase 2a clinical study in Parkinson's disease, including...